![An animal model of limitation of gut colonization by carbapenemase-producing Klebsiella pneumoniae using rifaximin | Scientific Reports An animal model of limitation of gut colonization by carbapenemase-producing Klebsiella pneumoniae using rifaximin | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-022-07827-8/MediaObjects/41598_2022_7827_Fig1_HTML.png)
An animal model of limitation of gut colonization by carbapenemase-producing Klebsiella pneumoniae using rifaximin | Scientific Reports
![Genomic dissection of Klebsiella pneumoniae infections in hospital patients reveals insights into an opportunistic pathogen | Nature Communications Genomic dissection of Klebsiella pneumoniae infections in hospital patients reveals insights into an opportunistic pathogen | Nature Communications](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41467-022-30717-6/MediaObjects/41467_2022_30717_Fig1_HTML.png)
Genomic dissection of Klebsiella pneumoniae infections in hospital patients reveals insights into an opportunistic pathogen | Nature Communications
![Clinical Outcomes in Bloodstream Infections Due to New Species, Klebsiella aerogenes - Infectious Disease Advisor Clinical Outcomes in Bloodstream Infections Due to New Species, Klebsiella aerogenes - Infectious Disease Advisor](https://www.infectiousdiseaseadvisor.com/wp-content/uploads/sites/16/2019/01/bacteriaklebsiellash58654766_1362008.jpg)
Clinical Outcomes in Bloodstream Infections Due to New Species, Klebsiella aerogenes - Infectious Disease Advisor
![Combination of pre-adapted bacteriophage therapy and antibiotics for treatment of fracture-related infection due to pandrug-resistant Klebsiella pneumoniae | Nature Communications Combination of pre-adapted bacteriophage therapy and antibiotics for treatment of fracture-related infection due to pandrug-resistant Klebsiella pneumoniae | Nature Communications](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41467-021-27656-z/MediaObjects/41467_2021_27656_Fig1_HTML.png)
Combination of pre-adapted bacteriophage therapy and antibiotics for treatment of fracture-related infection due to pandrug-resistant Klebsiella pneumoniae | Nature Communications
![TPGS-based and S-thanatin functionalized nanorods for overcoming drug resistance in Klebsiella pneumonia | Nature Communications TPGS-based and S-thanatin functionalized nanorods for overcoming drug resistance in Klebsiella pneumonia | Nature Communications](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41467-022-31500-3/MediaObjects/41467_2022_31500_Fig1_HTML.png)
TPGS-based and S-thanatin functionalized nanorods for overcoming drug resistance in Klebsiella pneumonia | Nature Communications
![Klebsiella species (K. pneumoniae, K. oxytoca, K. ozaenae and K. rhinoscleromatis) - Infectious Disease and Antimicrobial Agents Klebsiella species (K. pneumoniae, K. oxytoca, K. ozaenae and K. rhinoscleromatis) - Infectious Disease and Antimicrobial Agents](http://www.antimicrobe.org/images-Monographs/b107_f1.jpg)
Klebsiella species (K. pneumoniae, K. oxytoca, K. ozaenae and K. rhinoscleromatis) - Infectious Disease and Antimicrobial Agents
![Microorganisms | Free Full-Text | The PTS Components in Klebsiella pneumoniae Affect Bacterial Capsular Polysaccharide Production and Macrophage Phagocytosis Resistance Microorganisms | Free Full-Text | The PTS Components in Klebsiella pneumoniae Affect Bacterial Capsular Polysaccharide Production and Macrophage Phagocytosis Resistance](https://pub.mdpi-res.com/microorganisms/microorganisms-09-00335/article_deploy/html/images/microorganisms-09-00335-g001.png?1614937839)
Microorganisms | Free Full-Text | The PTS Components in Klebsiella pneumoniae Affect Bacterial Capsular Polysaccharide Production and Macrophage Phagocytosis Resistance
![Control of Klebsiella pneumoniae pulmonary infection and immunomodulation by oral treatment with the commensal probiotic Bifidobacterium longum 51A - ScienceDirect Control of Klebsiella pneumoniae pulmonary infection and immunomodulation by oral treatment with the commensal probiotic Bifidobacterium longum 51A - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1286457915002312-gr3.jpg)